Compare $EGRX vs $IMUC | Chartloom

Compare

$EGRX vs $IMUC

Eagle Pharmaceuticals Inc · Eom Pharmaceutical Holdings Inc

EGRX

Eagle Pharmaceuticals Inc

IMUC

Eom Pharmaceutical Holdings Inc

Compare $EGRX vs $IMUC

Comparing Eagle Pharmaceuticals Inc and Eom Pharmaceutical Holdings Inc

EGRXEagle Pharmaceuticals Inc

IMUCEom Pharmaceutical Holdings Inc

EGRXEagle Pharmaceuticals Inc

Market cap

$13M

P/E (TTM)

1.06x

Forward P/E (NTM)

0.25x

Forward P/S (NTM)

0.05x

Rev growth (TTM)

-5.4%

YTD performance

185.3%

52W performance

49.2%

FCF yield

-74.5%

IMUCEom Pharmaceutical Holdings Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.3%

52W performance

-31.7%

FCF yield

-18.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EGRX

IMUC

Detailed metrics comparison

EGRX

Eagle Pharmaceuticals Inc

IMUC

Eom Pharmaceutical Holdings Inc

Market Cap

EGRX$13M

IMUC$12M

Enterprise Value

EGRX$67M

IMUC$14M

Price

EGRX$0.97

IMUC$0.10

P/E Ratio

EGRX1.06x

IMUCN/A

P/S Ratio

EGRX0.05x

IMUC0.00x

EV/Sales

EGRX0.26x

IMUC0.00x

EV/EBITDA

EGRX1.07x

IMUC0.00x

P/B Ratio

EGRX0.05x

IMUC3.51x

P/FCF Ratio

EGRXN/A

IMUCN/A

EV/FCF

EGRX-7.18x

IMUC-6.11x

PEG Ratio

EGRXN/A

IMUCN/A

Forward P/E (NTM)

EGRX0.25x

IMUCN/A

Forward P/S (NTM)

EGRX0.05x

IMUCN/A

Revenue (TTM)

EGRX$258M

IMUC$0

Revenue Growth (YoY)

EGRX-5.4%

IMUCN/A

Forward Rev Growth

EGRX0.0%

IMUC0.0%

Gross Margin (TTM)

EGRX69.9%

IMUC0.0%

Operating Margin (TTM)

EGRX14.0%

IMUC0.0%

EBITDA Margin (TTM)

EGRX24.5%

IMUC0.0%

Net Margin (TTM)

EGRX4.7%

IMUC0.0%

FCF Margin (TTM)

EGRX-3.6%

IMUCN/A

Net Income (TTM)

EGRX$12M

IMUC$-6M

FCF (TTM)

EGRX$-9M

IMUC$-2M

EPS (TTM)

EGRX$0.92

IMUC-$0.05

ROE (TTM)

EGRX5.0%

IMUC-4502.0%

ROA (TTM)

EGRX3.0%

IMUC-45737.0%

ROIC (TTM)

EGRX3.9%

IMUC-4502.0%

Cash

EGRX$15M

IMUC$933K

Debt

EGRX$70M

IMUC$3M

Net Cash/Debt

EGRX$-55M

IMUC$-2M

Current Ratio (TTM)

EGRX2.16x

IMUC1.51x

Quick Ratio (TTM)

EGRX1.52x

IMUC1.28x

Debt/Equity (TTM)

EGRX0.28x

IMUC0.00x

Debt/Assets (TTM)

EGRX0.0%

IMUC0.0%

Interest Coverage (TTM)

EGRXN/A

IMUCN/A

Net Debt/EBITDA (TTM)

EGRX0.00x

IMUC0.00x

Beta

EGRX0.88

IMUC0.80

52W Performance

EGRX49.2%

IMUC-31.7%

YTD Performance

EGRX185.3%

IMUC-51.3%

% from 52W High

EGRX-74.9%

IMUC-72.1%

% from 52W Low

EGRX88081.8%

IMUC375.0%

Asset Turnover (TTM)

EGRX0.64x

IMUC0.00x

FCF Yield (TTM)

EGRX-74.5%

IMUC-18.9%

Earnings Yield (TTM)

EGRX96.0%

IMUC-49.4%

Dividend Yield (TTM)

EGRXN/A

IMUCN/A

Rule of 40

EGRX-9.0

IMUC0.0

EV/GP/RG

EGRXN/A

IMUCN/A

Ticker research

View EGRX research View IMUC research

Metric	EGRX Eagle Pharmaceuticals Inc	IMUC Eom Pharmaceutical Holdings Inc
Market & Valuation
Market Cap	$13M	$12M
Enterprise Value	$67M	$14M
Price	$0.97	$0.10
P/E Ratio	1.06x	N/A
P/S Ratio	0.05x	0.00x
EV/Sales	0.26x	0.00x
EV/EBITDA	1.07x	0.00x
P/B Ratio	0.05x	3.51x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.18x	-6.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	0.25x	N/A
Forward P/S (NTM)	0.05x	N/A
Revenue & Growth
Revenue (TTM)	$258M	$0
Revenue Growth (YoY)	-5.4%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	69.9%	0.0%
Operating Margin (TTM)	14.0%	0.0%
EBITDA Margin (TTM)	24.5%	0.0%
Net Margin (TTM)	4.7%	0.0%
FCF Margin (TTM)	-3.6%	N/A
Net Income (TTM)	$12M	$-6M
FCF (TTM)	$-9M	$-2M
EPS (TTM)	$0.92	-$0.05
ROE (TTM)	5.0%	-4502.0%
ROA (TTM)	3.0%	-45737.0%
ROIC (TTM)	3.9%	-4502.0%
Financial Health
Cash	$15M	$933K
Debt	$70M	$3M
Net Cash/Debt	$-55M	$-2M
Current Ratio (TTM)	2.16x	1.51x
Quick Ratio (TTM)	1.52x	1.28x
Debt/Equity (TTM)	0.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	0.80
52W Performance	49.2%	-31.7%
YTD Performance	185.3%	-51.3%
% from 52W High	-74.9%	-72.1%
% from 52W Low	88081.8%	375.0%
Efficiency & Yields
Asset Turnover (TTM)	0.64x	0.00x
FCF Yield (TTM)	-74.5%	-18.9%
Earnings Yield (TTM)	96.0%	-49.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-9.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EGRX research	View IMUC research

Valuation

P/E Ratio

EGRX

1.06x

P/S Ratio

IMUC

0.00x

EGRX

0.05x

EV/FCF

EGRX

-7.18x

IMUC

-6.11x

Growth & revenue

Revenue Growth TTM

EGRX

-5.4%

Forward Revenue Growth

EGRX

0.0%

IMUC

0.0%

Profitability & performance

Gross Margin

EGRX

69.9%

IMUC

0.0%

ROE

EGRX

5.0%

IMUC

-4502.0%

FCF Yield %

IMUC

-18.9%

EGRX

-74.5%

52-Week Performance

EGRX

49.2%

IMUC

-31.7%

Detailed metrics comparison

EGRX

Eagle Pharmaceuticals Inc

IMUC

Eom Pharmaceutical Holdings Inc

Market Cap

EGRX$13M

IMUC$12M

Enterprise Value

EGRX$67M

IMUC$14M

Price

EGRX$0.97

IMUC$0.10

P/E Ratio

EGRX1.06x

IMUCN/A

P/S Ratio

EGRX0.05x

IMUC0.00x

EV/Sales

EGRX0.26x

IMUC0.00x

EV/EBITDA

EGRX1.07x

IMUC0.00x

P/B Ratio

EGRX0.05x

IMUC3.51x

P/FCF Ratio

EGRXN/A

IMUCN/A

EV/FCF

EGRX-7.18x

IMUC-6.11x

PEG Ratio

EGRXN/A

IMUCN/A

Forward P/E (NTM)

EGRX0.25x

IMUCN/A

Forward P/S (NTM)

EGRX0.05x

IMUCN/A

Revenue (TTM)

EGRX$258M

IMUC$0

Revenue Growth (YoY)

EGRX-5.4%

IMUCN/A

Forward Rev Growth

EGRX0.0%

IMUC0.0%

Gross Margin (TTM)

EGRX69.9%

IMUC0.0%

Operating Margin (TTM)

EGRX14.0%

IMUC0.0%

EBITDA Margin (TTM)

EGRX24.5%

IMUC0.0%

Net Margin (TTM)

EGRX4.7%

IMUC0.0%

FCF Margin (TTM)

EGRX-3.6%

IMUCN/A

Net Income (TTM)

EGRX$12M

IMUC$-6M

FCF (TTM)

EGRX$-9M

IMUC$-2M

EPS (TTM)

EGRX$0.92

IMUC-$0.05

ROE (TTM)

EGRX5.0%

IMUC-4502.0%

ROA (TTM)

EGRX3.0%

IMUC-45737.0%

ROIC (TTM)

EGRX3.9%

IMUC-4502.0%

Cash

EGRX$15M

IMUC$933K

Debt

EGRX$70M

IMUC$3M

Net Cash/Debt

EGRX$-55M

IMUC$-2M

Current Ratio (TTM)

EGRX2.16x

IMUC1.51x

Quick Ratio (TTM)

EGRX1.52x

IMUC1.28x

Debt/Equity (TTM)

EGRX0.28x

IMUC0.00x

Debt/Assets (TTM)

EGRX0.0%

IMUC0.0%

Interest Coverage (TTM)

EGRXN/A

IMUCN/A

Net Debt/EBITDA (TTM)

EGRX0.00x

IMUC0.00x

Beta

EGRX0.88

IMUC0.80

52W Performance

EGRX49.2%

IMUC-31.7%

YTD Performance

EGRX185.3%

IMUC-51.3%

% from 52W High

EGRX-74.9%

IMUC-72.1%

% from 52W Low

EGRX88081.8%

IMUC375.0%

Asset Turnover (TTM)

EGRX0.64x

IMUC0.00x

FCF Yield (TTM)

EGRX-74.5%

IMUC-18.9%

Earnings Yield (TTM)

EGRX96.0%

IMUC-49.4%

Dividend Yield (TTM)

EGRXN/A

IMUCN/A

Rule of 40

EGRX-9.0

IMUC0.0

EV/GP/RG

EGRXN/A

IMUCN/A

Ticker research

View EGRX research View IMUC research

Metric	EGRX Eagle Pharmaceuticals Inc	IMUC Eom Pharmaceutical Holdings Inc
Market & Valuation
Market Cap	$13M	$12M
Enterprise Value	$67M	$14M
Price	$0.97	$0.10
P/E Ratio	1.06x	N/A
P/S Ratio	0.05x	0.00x
EV/Sales	0.26x	0.00x
EV/EBITDA	1.07x	0.00x
P/B Ratio	0.05x	3.51x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.18x	-6.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	0.25x	N/A
Forward P/S (NTM)	0.05x	N/A
Revenue & Growth
Revenue (TTM)	$258M	$0
Revenue Growth (YoY)	-5.4%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	69.9%	0.0%
Operating Margin (TTM)	14.0%	0.0%
EBITDA Margin (TTM)	24.5%	0.0%
Net Margin (TTM)	4.7%	0.0%
FCF Margin (TTM)	-3.6%	N/A
Net Income (TTM)	$12M	$-6M
FCF (TTM)	$-9M	$-2M
EPS (TTM)	$0.92	-$0.05
ROE (TTM)	5.0%	-4502.0%
ROA (TTM)	3.0%	-45737.0%
ROIC (TTM)	3.9%	-4502.0%
Financial Health
Cash	$15M	$933K
Debt	$70M	$3M
Net Cash/Debt	$-55M	$-2M
Current Ratio (TTM)	2.16x	1.51x
Quick Ratio (TTM)	1.52x	1.28x
Debt/Equity (TTM)	0.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	0.80
52W Performance	49.2%	-31.7%
YTD Performance	185.3%	-51.3%
% from 52W High	-74.9%	-72.1%
% from 52W Low	88081.8%	375.0%
Efficiency & Yields
Asset Turnover (TTM)	0.64x	0.00x
FCF Yield (TTM)	-74.5%	-18.9%
Earnings Yield (TTM)	96.0%	-49.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-9.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EGRX research	View IMUC research